Repeat biopsy for mutational analysis of non-small cell lung cancers resistant to previous chemotherapy: adequacy and complications.
about
Role of rebiopsy in relapsed non-small cell lung cancer for directing oncology treatmentsClinicopathological and demographical characteristics of non-small cell lung cancer patients with ALK rearrangements: a systematic review and meta-analysis.Liquid biopsy genotyping in lung cancer: ready for clinical utility?Quantitative CT variables enabling response prediction in neoadjuvant therapy with EGFR-TKIs: are they different from those in neoadjuvant concurrent chemoradiotherapy?Re-biopsy by endobronchial ultrasound procedures for mutation analysis of non-small cell lung cancer after EGFR tyrosine kinase inhibitor treatment.Rebiopsy for patients with non-small-cell lung cancer after epidermal growth factor receptor-tyrosine kinase inhibitor failure.Accuracy of transbronchial biopsy as a rebiopsy method for patients with relapse of advanced non-small-cell lung cancer after systemic chemotherapy.Diagnostic challenges in non-small-cell lung cancer: an integrated medicine approach.Management of EGFR-mutated non-small-cell lung cancer: practical implications from a clinical and pathology perspective.PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementation.Helical-Tip Needle for Transthoracic Percutaneous Image-Guided Biopsy of Lung Tumors: Results of a Pilot Prospective Comparative Study with a Standard Tru-Cut Needle.The Role of Interventional Oncology in the Management of Lung Cancer.Understanding Mechanisms of Resistance in the Epithelial Growth Factor Receptor in Non-Small Cell Lung Cancer and the Role of Biopsy at Progression.Osimertinib for the treatment of non-small cell lung cancer.CT-guided needle lung biopsy is possible during apneic oxygenation: a case series.Bronchoscopic Re-biopsy for Mutational Analysis of Non-small Cell Lung Cancer.Practice Pattern of Transthoracic Needle Biopsy: 2016 Survey in the Members of Korean Society of Thoracic Radiology.Feasibility of tissue re-biopsy in non-small cell lung cancers resistant to previous epidermal growth factor receptor tyrosine kinase inhibitor therapies.Urine test for EGFR analysis in patients with non-small cell lung cancer.Urinary cell-free DNA as a prognostic marker for KRAS-positive advanced-stage NSCLC.Repeat biopsy of patients with acquired resistance to EGFR TKIs: implications of biopsy-related factors on T790M mutation detection.Pathologic Diagnosis and Genetic Analysis of a Lung Tumor Needle Biopsy Specimen Obtained Immediately After Radiofrequency Ablation.Validation of the digital PCR system in tyrosine kinase inhibitor-resistant EGFR mutant non-small-cell lung cancer.Usefulness of Bronchoscopic Rebiopsy of Non-Small Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor.Reliability of small biopsy or cytology for the diagnosis of pulmonary mucinous adenocarcinoma.Diagnostic yield of a biopsy performed immediately after lung radiofrequency ablation.Evidence-based best practices for EGFR T790M testing in lung cancer in Canada.Bronchovascular injury associated with clinically significant hemoptysis after CT-guided core biopsy of the lung: Radiologic and histopathologic analysisChinese multidisciplinary expert consensus: Guidelines on percutaneous transthoracic needle biopsy
P2860
Q26852206-41C754F9-5FFE-4EE6-A993-41D512BA8E5EQ31167585-C9EB23A9-B3D7-4892-B76E-312885637A7BQ33567037-6D24F6AE-14D2-44AA-96C1-2C49EE5D4EA0Q35106153-C54F5792-93E6-41BC-B73D-D0537802DDF2Q36085487-A29E8017-05B8-4BBA-A703-3D8B943228D0Q37098321-47A3810C-7083-484F-936F-EC23FBBF645DQ37598365-BDB4FEE1-78D1-4D4F-AEF8-D3FB8819C263Q38352879-DA49D17E-D117-4AA6-8CAA-BE17F516217BQ38685481-35F8FA64-624B-4749-94F3-C7F2A83E0C52Q38838347-1E2A42DC-8A0D-49AA-B5EE-02342B881C1FQ38996196-9133021E-E286-4F54-8E4A-883F9E690427Q38999221-4B125628-3E10-4666-A11B-6587C7552534Q39002233-8207DB76-FEA6-48CC-8309-199C82C939C7Q39002726-C2C57424-53CB-4CED-8130-BF3AB2EEAFE0Q39815018-8AB362BD-12D8-47FD-98CD-24646CF8D2FEQ39941747-CE583EBB-7B0F-498B-89D7-5358AA18DB57Q42702580-0A39B2C8-7CF5-43C4-B8BA-57DE26E2BEACQ47103202-8D291EDD-9969-4236-8584-94E384CB92DBQ47564108-124196B9-6DF1-4FB0-812D-E45D5FB58F80Q47759918-239C0923-9CF9-45D7-B19A-7E88750242ADQ47980253-1795097D-4C4D-4451-83C8-67758392CE9FQ48257915-DE83C7C2-9EBA-43B7-80BC-10D6C810FF16Q48505836-D83A571F-AB4A-47F4-B820-75095BCD76B0Q52723939-F433AC3F-8BDB-4D61-BEE3-8275E15FB239Q53069432-EBE0618B-8E7F-4C4C-9ADF-3641DCAC8E75Q53084428-DE2586C2-E9AC-4B72-B5D2-76990BC77362Q54979898-F9DF97FB-5C0A-443F-9052-22C19577071BQ58707519-D9961D70-4E34-44F1-B2D4-D5DE73E3F412Q59137539-24A811E8-36C5-4FC8-8923-2E4525D40941
P2860
Repeat biopsy for mutational analysis of non-small cell lung cancers resistant to previous chemotherapy: adequacy and complications.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Repeat biopsy for mutational a ...... y: adequacy and complications.
@en
type
label
Repeat biopsy for mutational a ...... y: adequacy and complications.
@en
prefLabel
Repeat biopsy for mutational a ...... y: adequacy and complications.
@en
P2093
P356
P1433
P1476
Repeat biopsy for mutational a ...... y: adequacy and complications.
@en
P2093
Ho Yun Lee
Hyun Jung Yoon
Jhingook Kim
Jin Seok Ahn
Jong-Mu Sun
Keunchil Park
Kyung Soo Lee
Myung Jin Chung
Myung-Ju Ahn
P304
P356
10.1148/RADIOL.12112613
P407
P577
2012-08-28T00:00:00Z